Preventable drug-related morbidity and, mortality within nursing facilities represent a serious problem urgently requiring expert medical attention.
The health, care costs of drug-related problems can be both immense, and avoidable.
However, the research to date has been narrow in scope, focusing on the drug costs avoided and failing to consider the wider range of possible negative outcomes and potential drug-related problems., Objectives : To develop a model of therapeutic outcomes resulting from drug therapy within nursing facilities, to estimate the magnitude of the cost of drug-related morbidity and mortality within nursing facilities, in the United States, and to assess the impact of pharmacist-conducted, federally mandated, monthly, retrospective review of nursing facility residents'drug regimens in reducing the cost of drug-related morbidity and, mortality., Methods : Using decision analysis techniques, a probability pathway model was developed to estimate the cost, of drug-related problems within nursing facilities.
An expert panel consisting of consultant pharmacists and physicians with practice experience in nursing facilities and, geriatric care was surveyed to determine conditional probabilities of therapeutic outcomes attributable to drug, therapy.
Health care utilization and associated costs derived from negative therapeutic outcomes were estimated. (...)
Mots-clés Pascal : Médicament, Morbidité, Mortalité, Analyse coût, Economie santé, Nursing, Equipement collectif, Homme, Etats Unis, Amérique du Nord, Amérique
Mots-clés Pascal anglais : Drug, Morbidity, Mortality, Cost analysis, Health economy, Nursing, Facility, Human, United States, North America, America
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 97-0534635
Code Inist : 002B30A05. Création : 13/02/1998.